Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity With the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tribbles 3 Regulates the Fibrosis Cytokine TGF-β1 Through ERK1/2-MAPK Signaling Pathway in Diabetic Nephropathy

Journal of Immunology Research
MedicineAllergyImmunology
2014English

Targeting the PI3K Signaling Pathway in Cancer

Current Opinion in Genetics and Development
GeneticsDevelopmental Biology
2010English

Targeting the AXL Signaling Pathway in Ovarian Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2016English

Identification of a Novel Tumor Angiogenesis Inhibitor Targeting SHH/Gli1 Signaling Pathway in Non-Small Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Paeonol Enhances Thrombus Recanalization by Inducing Vascular Endothelial Growth Factor 165 via ERK1/2 MAPK Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

CIIA Negatively Regulates the Ras-Erk1/2 Signaling Pathway Through Inhibiting the Ras-Specific GEF Activity of SOS1

Journal of Cell Science
Cell Biology
2014English

Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

A Novel CYR61-triggered ‘CYR61-αvβ3 Integrin Loop’ Regulates Breast Cancer Cell Survival and Chemosensitivity Through Activation of ERK1/ERK2 MAPK Signaling Pathway

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models

International Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy